Stifel Financial’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Stifel Financial’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-49,743	Closed	-$356K	–	3011
2020 Q1	$356K	Buy	49,743 +12,496	+34%	+$156K	﹤0.01%	2080
2019 Q4	$890K	Sell	37,247 -466	-1%	-$12.9K	﹤0.01%	1912
2019 Q3	$1.01M	Buy	37,713 +9,877	+35%	+$277K	﹤0.01%	1746
2019 Q2	$755K	Sell	27,836 -283	-1%	-$8.88K	﹤0.01%	1974
2019 Q1	$976K	Buy	+28,119	New	+$811K	﹤0.01%	1666
2018 Q4	–	Sell	-7,638	Closed	-$205K	–	2870
2018 Q3	$205K	Buy	7,638 +185	+2%	+$6.04K	﹤0.01%	2569
2018 Q2	$282K	Buy	+7,453	New	+$285K	﹤0.01%	2339
2018 Q1	–	Sell	-7,113	Closed	-$347K	–	2804
2017 Q4	$347K	Buy	7,113 +2,149	+43%	+$109K	﹤0.01%	2122
2017 Q3	$268K	Buy	+4,964	New	+$291K	﹤0.01%	2213

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Stifel Financial's PTLA Position: Q2 2020 in Review

Stifel Financial sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 49,743 shares — an estimated $356K sold.

Stifel Financial first reported a position in PTLA in Q3 2017 and held it in 9 quarters. The position peaked at $1.01M in Q3 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Stifel Financial reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Stifel Financial sold 49,743 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $356K.
Stifel Financial first reported a position in Portola Pharmaceuticals, Inc. in Q3 2017 and held it in 9 quarters.
Stifel Financial's Portola Pharmaceuticals, Inc. position peaked at $1.01M in Q3 2019.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Stifel Financial's 13F filing for Q2 2020, filed 14 Aug 2020.